<HTML>
<!-- Produced by edgar-services.com using EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2019 [PPXZRS4DKJZLVHKMZEE5]. www.edgarsuite.com -->
<HEAD>
<TITLE>Current Event Report - Form 8-K</TITLE>
</HEAD>
<BODY>
<DIV style=margin-left:54pt;width:504pt><P style='font:16pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:16pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:16pt Times New Roman;margin:0'>UNITED STATES</P>
<P align=center style='font:16pt Times New Roman;margin:0'>SECURITIES AND EXCHANGE COMMISSION</P>
<P align=center style='font:14pt Times New Roman;margin:0'>Washington, D.C. &nbsp;20549</P>
<P align=center style='font:14pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:14pt Times New Roman;margin:0'>Form 8-K</P>
<P align=center style='font:14pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:14pt Times New Roman;margin:0'>Current Report</P>
<P align=center style='font:14pt Times New Roman;margin:0'>Pursuant to Section 13 or 15(d) of the</P>
<P align=center style='font:14pt Times New Roman;margin:0'>Securities Act of 1934</P>
<P align=center style='font:14pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:12pt Times New Roman;margin:0'>Date of Report (Date of earliest event reported): &nbsp;September 11, 2019</P>
<P align=center style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:20pt Times New Roman;margin:0'><FONT style='border-bottom:2px solid #000000'><B>BioAdaptives Inc.</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>(Exact Name of Registrant as Specified in its Charter)</FONT></P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style='font-size:10pt;border-bottom:1px solid #000000'>Delaware &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;000-54949 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;  &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;46-2592228</FONT></P>
<P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:13.5pt'><FONT style=font-size:10pt>(State or other jurisdiction of</FONT></KBD><KBD style='position:absolute;font:10pt Times New Roman;margin-left:216pt'><FONT style=font-size:10pt> &nbsp; &nbsp;&nbsp;(Commission File</FONT></KBD><KBD style=margin-left:360pt></KBD><FONT style=font-size:10pt> &nbsp;(I.R.S. Employer Identification </FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:13.5pt'><FONT style=font-size:10pt> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporation)</FONT></KBD><KBD style='position:absolute;font:10pt Times New Roman;margin-left:216pt'><FONT style=font-size:10pt> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Number)</FONT></KBD><KBD style=margin-left:396pt></KBD><FONT style=font-size:10pt>No.)</FONT>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0;text-indent:13.5pt'>&nbsp;</P>
<P align=center style='font:12pt Times New Roman;margin:0;text-indent:13.5pt'><FONT style='border-bottom:1px solid #000000'>2620 Regatta Drive, Suite 102, Las Vegas, Nevada &nbsp;89128</FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0;text-indent:13.5pt'><FONT style=font-size:10pt>(Address of principal executive offices)</FONT></P>
<P align=center style='font:11pt Times New Roman;margin:0;text-indent:13.5pt'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;text-indent:13.5pt'><FONT style=font-size:10pt>Registrant&#8217;s telephone number, including area code: &nbsp;(702) 659 8829</FONT></P>
<P align=center style='font:11pt Times New Roman;margin:0;text-indent:13.5pt'>&nbsp;</P>
<P align=center style='font:12pt Times New Roman;margin:0;text-indent:13.5pt'>N/A</P>
<P align=center style='font:10pt Times New Roman;margin:0;text-indent:13.5pt'><FONT style=font-size:10pt>(Former name or former address, if changed since last report)</FONT></P>
<P align=center style='font:11pt Times New Roman;margin:0;text-indent:13.5pt'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0;text-indent:13.5pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;margin-left:13.5pt'><FONT style=font-size:10pt>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</FONT></P>
<P align=justify style='font:11pt Times New Roman;margin:0;text-indent:13.5pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:13.5pt'><FONT style=font-size:10pt>[ &nbsp;] &nbsp;&nbsp;&nbsp;&nbsp;Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:13.5pt'><FONT style=font-size:10pt>[ &nbsp;] &nbsp;&nbsp;&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:13.5pt'><FONT style=font-size:10pt>[ &nbsp;] &nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:13.5pt'><FONT style=font-size:10pt> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CFR 240.14d-2(b))</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:13.5pt'><FONT style=font-size:10pt>[ &nbsp;] &nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:13.5pt'><FONT style=font-size:10pt> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CFR 240.13e-4(c))</FONT></P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'><B>Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</B></P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'><FONT style='border-bottom:1px solid #000000'>On September 11, 2019, BioAdaptives, Inc. (the &#8220;Company&#8221;) announced changes in its management.</FONT></P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:13.5pt'><FONT style='border-bottom:1px solid #000000'>Appointment of Robert W. Ellis, as Company President</FONT></P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>On September 11, 2019, Director and Chief Executive Officer,Dr. Edward E.Jacobs, Jr., announced the appointment of Mr. Robert Ellis to the position of President of the Company, replacing Dr. Jacobs, who had been acting as President. Dr. Jacobs continues in his role of Director and CEO. This appointment parallels the Company&#8217;s return to an SEC fully-reporting entity.</P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'><FONT style='border-bottom:1px solid #000000'>Biographical Information for Robert Ellis</FONT></P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>Robert Ellis brings more than forty years of business management experience to the Company. He has worked extensively in senior positions across a variety of industry disciplines, including aerospace, electronics, communications, and international marketing. Mr. Ellis has been an executive officer in private and public companies, both major entities, start-ups, and emerging entities. He has an Accounting Degree from the University of Illinois, and is a CPA.</P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'><FONT style='border-bottom:1px solid #000000'>On September 18, 2019, the Company announced the appointment of Bruce Colclasure as the President of its new majority owned subsidiary, Livestock Impact, Inc.</FONT></P>
<P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'><FONT style='border-bottom:1px solid #000000'>Biographical Information for Bruce Colclasure</FONT></P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>Bruce Colclasure has more than fifty years&#8217; experience working with livestock and their wellness. He is nationally recognized as an outstanding breeder and trainer of rodeo and show horses. He has numerous national and world championships to his credit, both as a trainer and as a performer, especially known for his work with cutting horses. Mr. Colclasure has worked with the Company for several years, assisting with solutions for livestock nutrition and wellness, using his expertise as an Animal Science and Nutrition major at Panhandle State University in Texas. As a trainer and performer he has worked with some of the world&#8217;s finest equine athletes, contributing to more than seventy World Championships. He has shown that the wellness products for horses are equally as effective for cattle, other livestock, and household pets. </P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:13.5pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:13.5pt'><FONT style='border-bottom:1px solid #000000'>On September 24, 2019, the Company announced Appointment of Ron Lambrecht as CFO</FONT></P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:13.5pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>On September 24, 2019, the Company appointed Ron Lambrecht as its Chief Financial Officer effective on October 01, 2019. Mr. Lambrecht will report to the Company CEO and to the President. </P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:13.5pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:13.5pt'><FONT style='border-bottom:1px solid #000000'>Biographical Information for Ron Lambrecht</FONT></P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>Ron Lambrecht is a successful businessman from Western Montana. He is a CPA and has operated a financial services business for more than 30 years. As a finance participant, he has been involved in a number of technology acquisitions and joint ventures. He graduated from the University of Montana in 1971 with a degree in Accountancy. Mr. Lambrecht is recognized as an expert in the fields of surface mining in addition to oil and gas exploration.</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'><B>Item 8.01 Other Events.</B></P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:13.5pt'><FONT style='border-bottom:1px solid #000000'>On September 18, 2019 the Company announced the Formation of Livestock Impact, Inc</FONT>. </P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:13.5pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>On September 18, 2019, Dr. Jacobs, Director and CEO announced the creation of a new majority-owned subsidiary of the Company, Livestock Impact, Inc. The Subsidiary has been formed to concentrate on developing and marketing nutritional wellness and health products developed by the Company specifically for the livestock industry. Leading the Subsidiary as a Director and the President is Mr. Bruce Colclasure, a well-known and successful livestock nutritionist and trainer of western-discipline horses. </P>
<P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'><FONT style='border-bottom:1px solid #000000'>On September 24, 2019, the Company announced the formation of a new operating division, TizHemp</FONT></P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>On September 24, 2019, a new operating division within the Company was created to concentrate efforts on the development and marketing of wellness-related hemp-based nutritional products. This Hemp initiative is a natural complement to the Company&#8217;s primary line of healthcare products. As a supporter of the health benefits of Hemp, the Company plans to introduce a line of products promoting general health and wellness, including topicals, nutritional powders and an assortment of tea.</P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>Press Release</P>
<P align=justify style='font:11pt Times New Roman;margin:0;margin-left:13.5pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>Attached as Exhibits 99.1,99.2 and 99.3 are copies of press releases from the Company dated September 11, 18 and 24, 2019 reporting Management changes and subsequent events </P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'><FONT style='border-bottom:1px solid #000000'><B>Item 9.01 Financial Statements and Exhibits</B></FONT></P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>Exhibit Description</P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'><A href=ba_ex99z1.htm style=text-decoration:none><FONT style='color:#0000FF;border-bottom:1px solid #0000FF'>99.1 Press Release of BioAdaptives, Inc dated September 11, 2019</FONT></A></P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'><A href=ba_ex99z2.htm style=text-decoration:none><FONT style='color:#0000FF;border-bottom:1px solid #0000FF'>99.2 Press Release of BioAdaptives, Inc dated September 18, 2019</FONT></A></P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'><A href=ba_ex99z3.htm style=text-decoration:none><FONT style='color:#0000FF;border-bottom:1px solid #0000FF'>99.3 Press Release of BioAdaptives, Inc dated September 24, 2019</FONT></A></P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>&nbsp;</P>
<P align=justify style='font:11pt Times New Roman;margin:0;margin-left:13.5pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>SIGNATURES</P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>
<P style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>&nbsp;</P>
<P style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>Dated: September 24, 2019</P>
<P style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>&nbsp;</P>
<P style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>BioAdaptives, Inc.</P>
<P style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>&nbsp;</P>
<P style='font:12pt Times New Roman;margin:0;text-indent:13.5pt'>By/s/<FONT style='border-bottom:1px solid #000000'>Edward E. Jacobs, Jr</FONT></P>
<P style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>Edward E. Jacobs, Jr</P>
<P style='font:12pt Times New Roman;margin:0;margin-left:13.5pt'>Director &amp; Chief Executive Officer</P>
</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "ba_8k.htm", "description": "CURRENT EVENT REPORT - FORM 8-K", "secsgml_size_bytes": 17850}]
{"company-data": {"conformed-name": "BIOADAPTIVES, INC.", "cik": "0001575142", "assigned-sic": "6770", "irs-number": "462592228", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54949", "film-number": "191121711"}, "business-address": {"street1": "1015 S CIMARRON RD", "city": "LAS VEGAS", "state": "NV", "zip": "89145", "phone": "(702) 560-1632"}, "mail-address": {"street1": "1015 S CIMARRON RD", "city": "LAS VEGAS", "state": "NV", "zip": "89145"}, "former-company": {"former-conformed-name": "APEX 8 Inc.", "date-changed": "20130424"}}
Current Event Report - Form 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Act of 1934
Date of Report (Date of earliest event reported):  September 11, 2019
BioAdaptives Inc.
(Exact Name of Registrant as Specified in its Charter)
Delaware                                               000-54949                                                 46-2592228
(State or other jurisdiction of
(Commission File
(I.R.S. Employer Identification
Incorporation)
Number)
No.)
2620 Regatta Drive, Suite 102, Las Vegas, Nevada  89128
(Address of principal executive offices)
Registrant's telephone number, including area code:  (702) 659 8829
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[  ]     Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
[  ]     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On September 11, 2019, BioAdaptives, Inc. (the "Company") announced changes in its management.
Appointment of Robert W. Ellis, as Company President
On September 11, 2019, Director and Chief Executive Officer,Dr. Edward E.Jacobs, Jr., announced the appointment of Mr. Robert Ellis to the position of President of the Company, replacing Dr. Jacobs, who had been acting as President. Dr. Jacobs continues in his role of Director and CEO. This appointment parallels the Company's return to an SEC fully-reporting entity.
Biographical Information for Robert Ellis
Robert Ellis brings more than forty years of business management experience to the Company. He has worked extensively in senior positions across a variety of industry disciplines, including aerospace, electronics, communications, and international marketing. Mr. Ellis has been an executive officer in private and public companies, both major entities, start-ups, and emerging entities. He has an Accounting Degree from the University of Illinois, and is a CPA.
On September 18, 2019, the Company announced the appointment of Bruce Colclasure as the President of its new majority owned subsidiary, Livestock Impact, Inc.
Biographical Information for Bruce Colclasure
Bruce Colclasure has more than fifty years' experience working with livestock and their wellness. He is nationally recognized as an outstanding breeder and trainer of rodeo and show horses. He has numerous national and world championships to his credit, both as a trainer and as a performer, especially known for his work with cutting horses. Mr. Colclasure has worked with the Company for several years, assisting with solutions for livestock nutrition and wellness, using his expertise as an Animal Science and Nutrition major at Panhandle State University in Texas. As a trainer and performer he has worked with some of the world's finest equine athletes, contributing to more than seventy World Championships. He has shown that the wellness products for horses are equally as effective for cattle, other livestock, and household pets.
On September 24, 2019, the Company announced Appointment of Ron Lambrecht as CFO
On September 24, 2019, the Company appointed Ron Lambrecht as its Chief Financial Officer effective on October 01, 2019. Mr. Lambrecht will report to the Company CEO and to the President.
Biographical Information for Ron Lambrecht
Ron Lambrecht is a successful businessman from Western Montana. He is a CPA and has operated a financial services business for more than 30 years. As a finance participant, he has been involved in a number of technology acquisitions and joint ventures. He graduated from the University of Montana in 1971 with a degree in Accountancy. Mr. Lambrecht is recognized as an expert in the fields of surface mining in addition to oil and gas exploration.
Item 8.01 Other Events.
On September 18, 2019 the Company announced the Formation of Livestock Impact, Inc
.
On September 18, 2019, Dr. Jacobs, Director and CEO announced the creation of a new majority-owned subsidiary of the Company, Livestock Impact, Inc. The Subsidiary has been formed to concentrate on developing and marketing nutritional wellness and health products developed by the Company specifically for the livestock industry. Leading the Subsidiary as a Director and the President is Mr. Bruce Colclasure, a well-known and successful livestock nutritionist and trainer of western-discipline horses.
On September 24, 2019, the Company announced the formation of a new operating division, TizHemp
On September 24, 2019, a new operating division within the Company was created to concentrate efforts on the development and marketing of wellness-related hemp-based nutritional products. This Hemp initiative is a natural complement to the Company's primary line of healthcare products. As a supporter of the health benefits of Hemp, the Company plans to introduce a line of products promoting general health and wellness, including topicals, nutritional powders and an assortment of tea.
Press Release
Attached as Exhibits 99.1,99.2 and 99.3 are copies of press releases from the Company dated September 11, 18 and 24, 2019 reporting Management changes and subsequent events
Item 9.01 Financial Statements and Exhibits
Exhibit Description
99.1 Press Release of BioAdaptives, Inc dated September 11, 2019
99.2 Press Release of BioAdaptives, Inc dated September 18, 2019
99.3 Press Release of BioAdaptives, Inc dated September 24, 2019
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: September 24, 2019
BioAdaptives, Inc.
By/s/
Edward E. Jacobs, Jr
Edward E. Jacobs, Jr
Director & Chief Executive Officer